載入...
Successful treatment with sorafenib in patients with advanced hepatocellular carcinoma: clinical case
Multi-kinase inhibitor sorafenib is the only one drug which increases life time in patients with advanced hepatocellular carcinoma (HCC). Results from the SHARP trial showed that median progression-free survival was less than 5 months. However, it is possible to achieve strong treatment effect for s...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Russo |
| 出版: |
IP Habib O.N.
2014-06-01
|
| 叢編: | Современная онкология |
| 主題: | |
| 在線閱讀: | https://modernonco.orscience.ru/1815-1434/article/view/26969 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|